SCHOTT Pharma AG & Co. KGaA (IT:1SXP)
:1SXP
1SXP Stock Chart & Stats
€19.94
--
Market closed
€19.94
--
Day’s Range― - ―
52-Week Range€7.00 - €30.85
Previous CloseN/A
VolumeN/A
Average Volume (3M)173.00
Market Cap
€2.65B
Enterprise Value€3.24B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)18.4
Beta0.73
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.62%
Share Statistics
EPS (TTM)0.21
Shares Outstanding150,614,610
10 Day Avg. Volume218
30 Day Avg. Volume173
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€19.20Price Target Upside-3.71% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
1SXP FAQ
What was SCHOTT Pharma AG & Co. KGaA’s price range in the past 12 months?
SCHOTT Pharma AG & Co. KGaA lowest stock price was €7.00 and its highest was €30.85 in the past 12 months.
What is SCHOTT Pharma AG & Co. KGaA’s market cap?
SCHOTT Pharma AG & Co. KGaA’s market cap is €2.65B.
When is SCHOTT Pharma AG & Co. KGaA’s upcoming earnings report date?
SCHOTT Pharma AG & Co. KGaA’s upcoming earnings report date is Aug 12, 2026 which is in 59 days.
How were SCHOTT Pharma AG & Co. KGaA’s earnings last quarter?
SCHOTT Pharma AG & Co. KGaA released its earnings results on May 13, 2026. The company reported €0.206 earnings per share for the quarter, beating the consensus estimate of N/A by €0.206.
Is SCHOTT Pharma AG & Co. KGaA overvalued?
According to Wall Street analysts SCHOTT Pharma AG & Co. KGaA’s price is currently Overvalued.
Does SCHOTT Pharma AG & Co. KGaA pay dividends?
SCHOTT Pharma AG & Co. KGaA does not currently pay dividends.
What is SCHOTT Pharma AG & Co. KGaA’s EPS estimate?
SCHOTT Pharma AG & Co. KGaA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SCHOTT Pharma AG & Co. KGaA have?
SCHOTT Pharma AG & Co. KGaA has 150,614,610 shares outstanding.
What happened to SCHOTT Pharma AG & Co. KGaA’s price movement after its last earnings report?
SCHOTT Pharma AG & Co. KGaA reported an EPS of €0.206 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.507%.
Which hedge fund is a major shareholder of SCHOTT Pharma AG & Co. KGaA?
Currently, no hedge funds are holding shares in IT:1SXP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
1SXP Stock 12 Month Forecast
Average Price Target
€19.20
▼(-3.71% Downside)